MedPath
HSA Approval

TRICOR TABLET 160 MG

SIN17013P

TRICOR TABLET 160 MG

TRICOR TABLET 160 MG

May 29, 2024

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C10AB05

Manufacturer Information

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

Astrea Fontaine

Active Ingredients

Fenofibrate

160 mg

Fenofibrate

Documents

Package Inserts

Tricor Tablet 160mg package Insert.pdf

Approved: May 29, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRICOR TABLET 160 MG - HSA Approval | MedPath